Key facts
- Folia Health’s last known valuation is $36.5M (Oct 2025).
- It has raised $17.8M across 3 recorded rounds; the latest was Early Stage VC ($6.0M) in Nov 2021.
- Notable investors include MassChallenge, Correlation Ventures, Joyance Partners, Bantam Group, Crosslink Capital — 14 tracked in total.
- Folia Health has filed 4 Form Ds with the SEC since 2017, most recently Nov 2021 ($6.0M sold to 14 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for Folia Health
Funding rounds
3 roundsAbout Folia Health
Developer of a patient management tool intended to provide patient-driven care for complex diseases. The company's tool helps parents become caregivers for kids with chronic conditions and contributes to precision diagnostics, patient-centered drug development, and better care through longitudinal data and proprietary analytic methods, enabling family members to keep track of all the small day-to-day changes in their child and access a vital and missing piece in the emergence of a home-centered, data-driven healthcare ecosystem.
- Sector
- Healthcare
- HQ
- Boston, MA, United States
- Founded
- 2016
- Employees
- 37
- Website
- foliahealth.com/
- Ownership
- Privately Held (backing)
Folia Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Folia Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Folia Health in its N-PORT filings yet. We sweep new filings monthly.